SEO URLwww.firestrike.ai/deals/applied-therapeutics-cycle-pharma-acquisition-2026
acquisitionAnnounced · Feb 3, 2026biopharmaceuticalSource · CredibleArticle · Factual
Cycle Pharma acquires Applied Therapeutics
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
Applied Therapeutics
NASDAQ: APLT · New York City, New York
Acquirer
Cycle Pharma
Full Acquisition
Status
Announced
Cycle Pharma agreed to acquire Applied Therapeutics. Reported deal value: Undisclosed. Status: Announced. Sector: biopharmaceutical. Target headquarters context: New York City, New York, United States.
This page summarizes publicly available information about the transaction as of 2026-02-03. Figures and status may change as filings and press coverage update.
Search jobs 03-Feb-2026 Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics to Expand Rare Disease Focus Cycle Pharmaceuticals has completed its acquisition of Applied Therapeutics , a clinical-stage biopharmaceutical company focused on rare disease treatments
Deal timeline
Announced
Feb 3, 2026 · pharmiweb.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in biopharmaceutical. Figures and status may change as sources update.
Sources: pharmiweb.com · Primary article · FireStrike proprietary index